2007

1. Rapid and durable antiretroviral effect of the HIV-1 integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: Results of a 48-week controlled study

   Journal of Acquired Immune Deficiency Syndromes, Vol. 46, Núm. 2, pp. 125-133